Date: 02/04/2025

The patient, who had been unresponsive to conventional therapies, demonstrated remarkable improvement with dupilumab, a monoclonal antibody initially approved for atopic dermatitis. 

https://www.dermatologytimes.com/view/what-s-new-in-the-medicine-chest-hailey-hailey-disease

Share This Page:

Search